{menu:{"children":[{"url":"co/Chapitre_2.html","label":"Chapitre II : Immunothérapie des Maladies Autoimmunes","source":"ueDiv","className":"mnu_ueDiv","id":"WCXpiQWhbqkUC0a4lrhZic","children":[{"url":"co/Chapitre_2_1.html","label":"Objectifs spécifiques","source":"expUc","className":"mnu_expUc","id":"oA3sFfVQVihipz6TKYLHHc"},{"url":"co/Chapitre_2_2.html","label":"Prérequis","source":"expUc","className":"mnu_expUc","id":"VxTsUZ09QXiQ0yihQumIe"},{"url":"co/Chapitre_2_3.html","label":"Généralités","source":"expUc","className":"mnu_expUc","id":"YKODUqSqOWdxPv1UjS7v9d"},{"url":"co/Chapitre_2_4.html","label":"Polyarthrite rhumatoïde","source":"ueDiv","className":"mnu_ueDiv","id":"D8zw3ILQEYeVZl3sAJMhOc","children":[{"url":"co/Chapitre_2_5.html","label":"Introduction","source":"intro","className":"mnu_intro","id":"D8zw3ILQEYeVZl3sAJMhOc"},{"url":"co/Chapitre_2_14.html","label":"Inhibiteurs de TNF","source":"expUc","className":"mnu_expUc","id":"JzU32mevTrlC2Sj79bKvc"},{"url":"co/Chapitre_2_15.html","label":"Inhibiteurs d\'interleukines","source":"expUc","className":"mnu_expUc","id":"Nl1o4SGoCchmFUf4Ttqosb"},{"url":"co/Chapitre_2_16.html","label":"Agents ciblant les lymphocytes","source":"expUc","className":"mnu_expUc","id":"wukwy6jKl7d8X3JfpFHMR"},{"url":"co/Chapitre_2_17.html","label":"Exercice","source":"field","className":"mnu_trainUc","id":"cHIymoh5MocUuaXOlozKVe"},{"url":"co/Chapitre_2_18.html","label":"Exercice","source":"mcqSur","className":"mnu_trainUc","id":"daxKjj14Bnhbi7pjhAsilb"}]},{"url":"co/Chapitre_2_6.html","label":"Diabète de type 1","source":"ueDiv","className":"mnu_ueDiv","id":"wE8xyb29GNbriRDx2VSeQe","children":[{"url":"co/Chapitre_2_7.html","label":"Introduction","source":"intro","className":"mnu_intro","id":"wE8xyb29GNbriRDx2VSeQe"},{"url":"co/Chapitre_2_19.html","label":"Thérapies spécifiques à l\'antigène","source":"expUc","className":"mnu_expUc","id":"TiHzjxoo65d2SCeYTaVDId"},{"url":"co/Chapitre_2_20.html","label":"Thérapies ciblant les cytokines","source":"expUc","className":"mnu_expUc","id":"otVAprYUJKfmMxwYM7k4Dd"},{"url":"co/Chapitre_2_21.html","label":"Thérapie cellulaire","source":"expUc","className":"mnu_expUc","id":"dIVhiIuybNbADEZAxJCvWg"},{"url":"co/Chapitre_2_22.html","label":"Exercice","source":"mcqSur","className":"mnu_trainUc","id":"FKtAErBdHMVfGSEiwnERd"}]},{"url":"co/Chapitre_2_8.html","label":"Sclérose en plaques","source":"ueDiv","className":"mnu_ueDiv","id":"UssATjmQjde3Z0p25LrTT","children":[{"url":"co/Chapitre_2_9.html","label":"Introduction","source":"intro","className":"mnu_intro","id":"UssATjmQjde3Z0p25LrTT"},{"url":"co/Chapitre_2_23.html","label":"Antagonistes de TLR","source":"expUc","className":"mnu_expUc","id":"hpYOIbmCzvhVQO5c6oNE3e"},{"url":"co/Chapitre_2_24.html","label":"Exercice","source":"mcqSur","className":"mnu_trainUc","id":"U5iV03kIHWilsIauorY0uf"}]},{"url":"co/Chapitre_2_10.html","label":"Psoriasis","source":"ueDiv","className":"mnu_ueDiv","id":"T7qmRBruK2g7QKCFM2hqPi","children":[{"url":"co/Chapitre_2_11.html","label":"Introduction","source":"intro","className":"mnu_intro","id":"T7qmRBruK2g7QKCFM2hqPi"},{"url":"co/Chapitre_2_25.html","label":"Antagonistes de TNF","source":"expUc","className":"mnu_expUc","id":"cOFkqbZtYblI0w81vA1Z3g"},{"url":"co/Chapitre_2_26.html","label":"Agents ciblant l\'interleukine 12 et interleukine 23","source":"expUc","className":"mnu_expUc","id":"uDMXrpJo65gMtfTIP97AKc"},{"url":"co/Chapitre_2_27.html","label":"Inhibiteurs d\'interleukine 17","source":"expUc","className":"mnu_expUc","id":"AEFHFkWuRzcqS2wVSc9p8c"},{"url":"co/Chapitre_2_28.html","label":"Inhibiteurs de la phosphodiestérase","source":"expUc","className":"mnu_expUc","id":"sYMejvgEykjZGbUnyoWyRf"},{"url":"co/Chapitre_2_29.html","label":"Inhibiteurs de Janus kinase","source":"expUc","className":"mnu_expUc","id":"G4PkGuVwHHkKKPPYkVTL"},{"url":"co/Chapitre_2_30.html","label":"Agonistes des récepteurs A3 de l\'adénosine","source":"expUc","className":"mnu_expUc","id":"kkdOjyzEV0j14rwqBUbb0"},{"url":"co/Chapitre_2_31.html","label":"Antagonistes d\'interleukine 1","source":"expUc","className":"mnu_expUc","id":"zHwIrB5atHh51aKTBT59Fg"},{"url":"co/Chapitre_2_32.html","label":"Exercice","source":"field","className":"mnu_trainUc","id":"AVDTT40K4Nh8nBTw0SxsHe"}]},{"url":"co/Chapitre_2_12.html","label":"Lupus érythémateux disséminé","source":"ueDiv","className":"mnu_ueDiv","id":"LmeH04J4ayeAEiqkjpuSof","children":[{"url":"co/Chapitre_2_13.html","label":"Introduction","source":"intro","className":"mnu_intro","id":"LmeH04J4ayeAEiqkjpuSof"},{"url":"co/Chapitre_2_33.html","label":"Thérapie cellulaire","source":"expUc","className":"mnu_expUc","id":"gTJMszZye0iXU9x4xHhlhf"},{"url":"co/Chapitre_2_34.html","label":"Thérapie peptidique","source":"expUc","className":"mnu_expUc","id":"KkgesWE0gXdn0ITKK8tvqb"},{"url":"co/Chapitre_2_35.html","label":"Agents ciblant BAFF","source":"expUc","className":"mnu_expUc","id":"WMJDJ2qP4lbnbfll1Ej4Fd"},{"url":"co/Chapitre_2_36.html","label":"Agents ciblant les molécules de costimulation","source":"expUc","className":"mnu_expUc","id":"gkz2YbdmG5gPOijueS8mSe"},{"url":"co/Chapitre_2_37.html","label":"Agents ciblant les cytokines","source":"expUc","className":"mnu_expUc","id":"fXFOnXMvgvlHlzBeBmygP"},{"url":"co/Chapitre_2_38.html","label":"Agents ciblant les lymphocytes B","source":"expUc","className":"mnu_expUc","id":"UHVGTbi0ENcMgvs4G1KC9d"},{"url":"co/Chapitre_2_39.html","label":"Inhibiteurs des molécules de signalisation","source":"expUc","className":"mnu_expUc","id":"uHVYfluiHDhF4Rmzm0l17b"},{"url":"co/Chapitre_2_40.html","label":"Exercice","source":"field","className":"mnu_trainUc","id":"nr7opk7P1wgpcxKV53ooGh"},{"url":"co/Chapitre_2_41.html","label":"Exercice","source":"mcqSur","className":"mnu_trainUc","id":"t5Puk6FaE1koe0y1Qq71uj"}]}]},{"url":"null","label":"","source":"ue","className":"hidden","id":"t4jkrfqm96hTg194guTVLc"}]}}